BOLT: Bolt Biotherapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.69
Enterprise Value ($M) 7.32
Book Value ($M) 72.03
Book Value / Share 1.88
Price / Book 0.23
NCAV ($M) 19.84
NCAV / Share 0.52
Price / NCAV 0.84

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.41
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 3.16
Current Ratio 3.16

Balance Sheet (mrq) ($M)
Current Assets 57.15
Assets 109.33
Liabilities 37.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Citadel Advisors Llc 0.00
2024-02-14 13G/A Tang Capital Partners Lp 9.60 33.67
2024-02-13 13G/A Vivo Capital VIII, LLC 5.50
2024-02-12 13D/A Pivotal bioVenture Partners Fund I, L.P. 8.10 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-10 9,700 71,521 13.56
2025-03-07 1,527 275,306 0.55
2025-03-06 6,866 73,187 9.38
2025-03-05 1,098 13,432 8.17

(click for more detail)

Similar Companies
BIVI – BioVie Inc. BMRA – Biomerica, Inc.
BNTC – Benitec Biopharma Inc. BON – Bon Natural Life Limited
BTAI – BioXcel Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io